Canto M.V., Guxens M., García-Altés A., López M.J., Marí-Dell’Olmo M., García-Pérez J., Ramis R.. Air Pollution and Birth Outcomes: Health Impact and Economic Value Assessment in Spain. International Journal of Environmental Research and Public Health. 2023; 20(3)DOI:10.3390/ijerph20032290. PMID:36767658. IF:(Q/D).

Casas-Deza D., Lamuela-Calvo L.J., Gomollón F., Arbonés-Mainar J.M., Caballol B., Gisbert J.P., Rivero M., Sánchez-Rodríguez E., García L.A., Casbas A.G., Merino O., Márquez L., Laredo V., Martín-Arranz M.D., Serrano P.L., Menéndez S.R., González-Muñoza C., Parga, LD, Moya M.C., Fuentes-Valenzuela E., Esteve M., Iborra M., Gil M.D., Barreiro-De Acosta, M, Lorente-Poyatos R.H., Mancenido, N, Calafat M., Rodríguez-Lago I., Capo J.G., Payeras M.A., Alvarado, VJM, Tardillo C., Bujanda L., Munoz-Nunez, JF, Nieto Y.B., Bermejo F., Almela P., Navarro-Llavat M., Montiel P.M., Gutiérrez C.R., Van Domselaar M., Sesé E., Pérez T.M., Ricart E., Chaparro M., García M.J., López-Sanromán A., Sicilia B., Orts B., López-García A., Martín-Arranz E., Pérez-Calle J.L., de Francisco R., García-Planella E., Domenech, E, García-López S.. Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry. Journal of Crohns & Colitis. 2023; 17(1)DOI:10.1093/ecco-jcc/jjac108. PMID:35913456. IF:8.300(Q1/1D).

Bracchiglione J., Rodríguez-Grijalva G., Requeijo C., Santero M., Salazar J., Salas-Gama K., Meade A.-G., Antequera A., Auladell-Rispau A., Quintana M.J., Solà I., Urrútia G., Acosta-Dighero R., Bonfill Cosp X.. Systemic Oncological Treatments versus Supportive Care for Patients with Advanced Hepatobiliary Cancers: An Overview of Systematic Reviews. Cancers. 2023; 15(3)DOI:10.3390/cancers15030766. PMID:36765723. IF:4.500(Q1/3D).

Álvarez-Velasco R., Dols-Icardo O., El Bounasri S., López-Vilaró L., Trujillo J.C., Reyes-Leiva D., Suárez-Calvet X., Cortés-Vicente E., Illa I., Gallardo E.. Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis. Neurology-Neuroimmunology & Neuroinflammation. 2023; 10(2)DOI:10.1212/NXI.0000000000200085. PMID:36697230. IF:8.300(Q1/1D).